Sell

ALNY Quote, Financials, Valuation and Earnings

Last price:

$245.56

Seasonality move :

2.78%

Day range:

$235.93 - $247.21

52-week range:

$141.98 - $304.39

Dividend yield:

0%

P/E ratio:

--

P/S ratio:

14.86x

P/B ratio:

978.70x

Volume:

1.3M

Avg. volume:

771.7K

1-year change:

37.11%

Market cap:

$31.7B

Revenue:

$1.8B

EPS (TTM):

-$2.62

Alnylam Pharmaceuticals SEC Filings

Company	Filed	Form Type	Description
ALNY Alnylam Pharmaceuticals	05/02/2024	10-Q	10-Q filing on 05/02/2024	View Form
ALNY Alnylam Pharmaceuticals	11/02/2023	10-Q	10-Q filing on 11/02/2023	View Form
ALNY Alnylam Pharmaceuticals	08/03/2023	10-Q	10-Q filing on 08/03/2023	View Form
ALNY Alnylam Pharmaceuticals	05/04/2023	10-Q	10-Q filing on 05/04/2023	View Form
ALNY Alnylam Pharmaceuticals	10/27/2022	10-Q	10-Q filing on 10/27/2022	View Form
ALNY Alnylam Pharmaceuticals	07/28/2022	10-Q	10-Q filing on 07/28/2022	View Form
ALNY Alnylam Pharmaceuticals	04/28/2022	10-Q	10-Q filing on 04/28/2022	View Form
ALNY Alnylam Pharmaceuticals	10/28/2021	10-Q	10-Q filing on 10/28/2021	View Form
ALNY Alnylam Pharmaceuticals	08/03/2021	10-Q	10-Q filing on 08/03/2021	View Form
ALNY Alnylam Pharmaceuticals	04/29/2021	10-Q	10-Q filing on 04/29/2021	View Form
ALNY Alnylam Pharmaceuticals	02/11/2021	10-K	10-K filing on 02/11/2021	View Form
ALNY Alnylam Pharmaceuticals	11/05/2020	10-Q	10-Q filing on 11/05/2020	View Form
ALNY Alnylam Pharmaceuticals	08/06/2020	10-Q	10-Q filing on 08/06/2020	View Form
ALNY Alnylam Pharmaceuticals	05/06/2020	10-Q	10-Q filing on 05/06/2020	View Form
ALNY Alnylam Pharmaceuticals	02/13/2020	10-K	10-K filing on 02/13/2020	View Form
ALNY Alnylam Pharmaceuticals	10/31/2019	10-Q	10-Q filing on 10/31/2019	View Form
ALNY Alnylam Pharmaceuticals	08/06/2019	10-Q	10-Q filing on 08/06/2019	View Form
ALNY Alnylam Pharmaceuticals	05/02/2019	10-Q	10-Q filing on 05/02/2019	View Form
ALNY Alnylam Pharmaceuticals	02/14/2019	10-K	10-K filing on 02/14/2019	View Form
ALNY Alnylam Pharmaceuticals	11/07/2018	10-Q	10-Q filing on 11/07/2018	View Form
ALNY Alnylam Pharmaceuticals	08/02/2018	10-Q	10-Q filing on 08/02/2018	View Form
ALNY Alnylam Pharmaceuticals	05/04/2018	10-Q	10-Q filing on 05/04/2018	View Form
ALNY Alnylam Pharmaceuticals	02/15/2018	10-K	10-K filing on 02/15/2018	View Form
ALNY Alnylam Pharmaceuticals	11/07/2017	10-Q	10-Q filing on 11/07/2017	View Form
ALNY Alnylam Pharmaceuticals	08/09/2017	10-Q	10-Q filing on 08/09/2017	View Form
ALNY Alnylam Pharmaceuticals	05/05/2017	10-Q	10-Q filing on 05/05/2017	View Form
ALNY Alnylam Pharmaceuticals	02/15/2017	10-K	10-K filing on 02/15/2017	View Form
ALNY Alnylam Pharmaceuticals	11/03/2016	10-Q	10-Q filing on 11/03/2016	View Form
ALNY Alnylam Pharmaceuticals	08/04/2016	10-Q	10-Q filing on 08/04/2016	View Form
ALNY Alnylam Pharmaceuticals	05/04/2016	10-Q	10-Q filing on 05/04/2016	View Form
ALNY Alnylam Pharmaceuticals	02/12/2016	10-K	10-K filing on 02/12/2016	View Form
ALNY Alnylam Pharmaceuticals	11/09/2015	10-Q	10-Q filing on 11/09/2015	View Form
ALNY Alnylam Pharmaceuticals	08/07/2015	10-Q	10-Q filing on 08/07/2015	View Form
ALNY Alnylam Pharmaceuticals	05/08/2015	10-Q	10-Q filing on 05/08/2015	View Form
ALNY Alnylam Pharmaceuticals	02/13/2015	10-K	10-K filing on 02/13/2015	View Form
ALNY Alnylam Pharmaceuticals	01/09/2015	10-Q	10-Q filing on 01/09/2015	View Form

Related Companies

Get ALNY Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ALNY

Sector

P/E ratio

--

25.86x

PEG ratio

--

0.00x

P/B ratio

978.70x

1.85x

Price / LTM sales

14.86x

1.86x

Growth Metrics

ALNY

Sector

Revenue growth

-33.26%

7.28%

Earnings growth

--

1.82%

Revenue (5-year growth)

89.45%

8.73%

Earnings forecast

-$0.39

-$0.20

Profitability

ALNY

Sector

Profitability FY 2023

$1.5B

$57.1M

Return on invested capital

-36.66%

-14.06%

Return on assets

-8.43%

-11.77%

Return on equity

--

-14.78%

Earnings Date

Last Earnings Date

Oct

31

Next Earnings Date

Feb

14

Estimated Next Earnings Date

Jan

30

Balance Sheet

ALNY

Sector

Total cash

$2.8B

$47M

Short term investments

$1.6B

$45.2M

Total assets

$3.8B

$142.6M

Long term debt

$1B

$6.5M

Stock Ideas

Buy

64

Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy or Sell?

Buy

52

Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy or Sell?

Buy

55

Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Buy or Sell?

Alerts

Buy

61

QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Buy or Sell?

Sell

46

NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Buy or Sell?

Sell

1

IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Alnylam Pharmaceuticals SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get ALNY Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

Will Tyson Foods Stock Bounce Back?

Will Iovance Biotherapeutics Stock Bounce Back?

Stock Ideas

Is AAPL Stock a Buy?

Is NVDA Stock a Buy?

Is MSFT Stock a Buy?

Alerts

QMCO alert for Dec 21

NUKK alert for Dec 21

IIPR alert for Dec 21

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS